Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (LS123)
Assay data:16 Active, 794 Tested
SummaryPubMed CitationRelated BioAssays by Depositor
Human kinome siRNA screen in A549-BTR and MDA-231-1833-BTR cells
Assay data:49 Active, 714 Tested
SummaryPubMed Citation
A whole genome RNAi screen highlights components of the ER/Golgi as a prominent source of resistance to immunotoxin-mediated cytotoxicity
Assay data:555 Active, 64752 Tested
InfectX: Pathogen infection siRNA screens
Assay data:115372 Tested
Identification of proteins required for the processing of the EWS-FLI1 nascent transcript
Assay data:59220 Tested
Summary
A screen to identify genes that regulate lymphatic endothelial cell migration - Primary Screen
Assay data:1034 Active, 18120 Tested
SummaryRelated BioAssays by Depositor
A screen to identify synthetic lethal interactions with E-cadherin in an MCF10A isogenic cell line
Assay data:2442 Active, 18052 Tested
Antagonist activity at human ACVR2B by Ant A204 luciferase reporter/summary (Abse5) assay
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of ACVR2B (unknown origin) assessed as residual activity at 1 uM by radiometric protein kinase assay
Genome-wide siRNA screen of genes regulating the Lipopolysaccharide-induced TNF-alpha response in human macrophages_Primary screen TNF readout
Assay data:2853 Active, 18113 Tested
SummaryRelated BioAssays by Same Project
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SW1463)
Assay data:9 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (NCIH716)
Assay data:13 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (HCC2998)
Assay data:10 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (CL40)
Assay data:15 Active, 794 Tested
Inhibition of AVR2B (unknown origin) assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (GP5D)
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SW1116)
Assay data:7 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (RKO)
Assay data:11 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (COLO320HSR)
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (C2BBE1)
Assay data:24 Active, 794 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on